Changsha Sanji Biotech Co. Ltd., part of Boai NKY Medical Holdings Ltd., is a company headquartered in Changshang, China, that engages in bio engineering technology development operation. Boai NKY Medical Holdings Ltd. acquired Changsha Sanji Biotech Co. Ltd. on November 13, 2014 for $35.94 million.

Enterprise Ireland is an Irish state economic development agency focused on helping Irish-owned business deliver new export sales. The aim of Enterprise Ireland is to accelerate the development of Irish enterprises capable of achieving strong positions in global markets resulting in increased national and regional prosperity and purchasing power.

Biotec Co. Ltd. is a private company headquartered in Japan. The firm designs, manufactures and supplies automated liquid-handling devices and microplate washers.

Shanghai Bode Gene Development Co., Ltd., established on 1998-03-22, Business scope includes bioengineering,Technology transfer in the field of genetic engineering expertise,technology development,technical consulting,Technical services and manufacture of related reagents and equipment,Sales;Bioengineering and Genetic Engineering Products,electronics,Chemical Products(In addition to dangerous goods)import and export business. [Items subject to approval by law,Business activities can only be carried out after approval by relevant departments]

Yeda Research and Development Company Ltd. is the commercial arm of the Weizmann Institute of Science. Yeda holds an exclusive agreement with the Weizmann Institute to commercialize the unique intellectual property developed by the scientists. The income generated serves to support further basic research and science education. - Identify and assess research projects with commercial potential. - Protect the intellectual property of the Institute and its scientists. - Create business relationships and license the Institute’s inventions and technologies to the industry. - Channel funding from industry to research projects. For further information please contact Tamir Huberman, CIO and Head of Marketing

Epigenomics is a molecular diagnostics company focusing on the development and commercialization of in vitro diagnostic tests for cancer. Its cancer diagnostic tests aim at finding cancer at early stages before symptoms occur and are carried out conveniently on body fluids such as blood plasma. These tests potentially address millions of individuals in each of the major markets such as the United States, Europe, and Japan and provide product opportunities each with peak sales potentials of several hundred millions of euros for diagnostics companies worldwide. Its lead test development program is in colorectal cancer. Further test are in development for lung and prostate cancer. Each of its products in development addresses either mass markets or high-value niches. While some of them lend themselves to partnering with established diagnostics industry players, others can be commercialized effectively by Epigenomics itself. The concept of its diagnostic tests in development relies on detecting differences in DNA methylation patterns between healthy and sick individuals or between subgroups of patients for disease classification.

Roche Diagnostics GmbH, part of Roche Holding AG, is a company headquartered in Mannheim, Germany, involved in laboratory analytical instruments. Andreas Schmitz and Claus Haberda are the current co-CEOs of the firm. On January 01, 1999 Roche Holding AG acquired Roche Diagnostics GmbH.

Epicentre, is a manufacturer and seller of high-quality molecular biology products for life science research, clinical research, molecular diagnostics and biopharmaceutical manufacturing. Products are available for RNA amplification and gene expression analysis, transposon-based genetic analysis, DNA and RNA purification, DNA sequencing, PCR and RT-PCR amplification, DNA and RNA modifying enzymes, genomic cloning, in vitro transcription, and protein research and purification. In addition to our broad molecular biology product line, Epicentre also offers custom protein manufacturing.

European Atomic Energy Community Euratom is a private company headquartered in Luxembourg, Luxembourg, that develops atomic energy.

SolGent Co., Ltd. provides solutions for molecular biology, molecular diagnostics and genetics. Its business areas are Molecular Diagnosis, Molecular Biology and Genetic Analysis Service. The firm's Molecular Diagnosis business develops pathogen detection and human genotype kit and microbial screening, Molecular Biology research offers amplification, cloning, and biological reagents and the Genetic Analysis Service provides sequencing, genotyping, DNA fingerprinting, and microorganism identification service. The company was founded in 2000 and is headquartered in Daejeon, South Korea.

Cepheid Inc (NASDAQ: CPHD) is an American molecular diagnostics company that develops, manufactures and markets fully integrated systems for testing in the clinical market, and for application in its original non-clinical market. The company's systems enable rapid, sophisticated molecular testing for organisms and genetic-based diseases by automating otherwise complex manual laboratory procedures. It was the winner of 2006 Industrial Design Excellence Awards for its product, Reagent Bead Dispenser. It won the federal contract by "MRSA Reagent Test Kits" in 2012. One of the company's customers is U.S. Food and Drug Administration (FDA). Danaher acquired Cepheid on November 4, 2016.

Applied Genetics, Inc. Dermatics develops and markets pharmaceutical drugs, skincare ingredients and prestige products. It develops array of cosmetic ingredients to use in skin care products. The company has focused on ingredients for skin protection from environmental damage. The firm also has a topical pharmaceutical product in clinical testing called Dimericine for cancer-prone skin. Applied Genetics was founded by Daniel B Yarosh and Karen Yarosh in May 1985 and is headquartered in Freeport, NY.

New England Biolabs is focused on the discovery and development of recombinant and native enzymes for genomic research. It offers restriction endonucleases for DNA digestion; PCR, polymerases, and amplification technologies for PCR applications; DNA modifying enzymes and cloning technologies; reagents for DNA and RNA sample preparation; DNA, RNA, and protein markers and ladders for electrophoresis applications; reagents for RNA research; and gene expression tools for DNA, RNA, and protein transfection of cell lines. The company also offers cellular analysis solutions; reagents, enzymes, antibodies, and DNA controls for epigenetics research; protein expression and purification technologies; competent cells for transformation and protein expression; protein tools; glycobiology products; and plasmids and DNAs for use in cloning experiments. New England Biolabs was founded in 1974 and is based in Ipswich, Massachusetts.

On 1 August 2014 following the commencement of the Industrial Development (Forfás Dissolution) Act 2014. Forfas’ policy functions were integrated with the Department of Jobs, Enterprise and Innovation. Forfás was Ireland’s policy advisory board for enterprise, trade, science, technology and innovation. Forfás was established in 1994 as an agency of the Department of Enterprise, Trade and Employment.

Pacific Biosciences of California, Inc. is an American biotechnology company founded in 2004 that develops and manufactures systems for gene sequencing and some novel real time biological observation. PacBio describes its platform as single molecule real time sequencing (SMRT), based on the properties of zero-mode waveguides. The company's first commercial product, the PacBio RS, was sold to a limited set of customers in 2010 and was commercially released in early 2011. A subsequent version of the sequencer called the PacBio RS II was released in April 2013. On 25 September 2013 a partnership between Pacific Biosciences and Roche Diagnostics was announced for the development of in vitro diagnostic products using the technology, with Roche providing US$75,000,000 in the deal. In 2015, the company launched a new sequencing instrument called the Sequel System with approximately 7-fold greater capacity than the PacBio RS II. Then in April 2019 the company launched the Sequel II system with a further 8-fold increase in throughput.

Shanghai Shipu Biotechnology Co., Ltd., established on 2017-04-26, Business scope includes biotechnology,Medical Technology(human stem cells,Except for the development and application of genetic diagnosis and treatment technology)Technology research and development in the field,own technology transfer,And provide relevant technical advice and technical services,Chemical raw materials and products(Removal of hazardous chemicals,Monitor Chemicals,civilian explosives,precursor chemicals)Wholesale and import and export,commission agent(except auction),And provide related supporting services.[Items subject to approval by law,Business activities can only be carried out after approval by relevant departments]

Part of Abbott Laboratories, Abbott Diagnostics Scarborough, Inc. is an American company specializing in surgical and medical instruments and apparatus.

F. Hoffmann-La Roche Ltd. manufactures pharmaceutical products. It offers pharmaceutical drugs, pharmaceutical instruments, and diagnostics solutions. The company was founded by Fritz Hoffmann-La Roche on October 1, 1896 and is headquartered in Basel, Switzerland.